Mel Sorensen is President and CEO of Galera Therapeutics, Inc.. Currently has a direct ownership of 265,029 shares of GRTX, which is worth approximately $13,251. The most recent transaction as insider was on Aug 16, 2024, when has been sold 67,015 shares (Common Stock) at a price of $0.07 per share, resulting in proceeds of $4,691. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 265K
20.18% 3M change
20.18% 12M change
Total Value Held $13,251

Mel Sorensen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2024
SELL
Open market or private sale
$4,691 $0.07 p/Share
67,015 Reduced 20.18%
265,029 Common Stock
Mar 10 2023
BUY
Open market or private purchase
$168,000 $1.68 p/Share
100,000 Added 23.15%
332,044 Common Stock
Mar 26 2021
BUY
Exercise of conversion of derivative security
$240,887 $1.11 p/Share
217,015 Added 48.33%
232,044 Common Stock
MS

Mel Sorensen

President and CEO
Malvern, PA

Track Institutional and Insider Activities on GRTX

Follow Galera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRTX shares.

Notify only if

Insider Trading

Get notified when an Galera Therapeutics, Inc. insider buys or sells GRTX shares.

Notify only if

News

Receive news related to Galera Therapeutics, Inc.

Track Activities on GRTX